42 related articles for article (PubMed ID: 17914094)
1. The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy.
Wu CT; Chen WC; Liao SK; Hsu CL; Lee KD; Chen MF
Endocr Relat Cancer; 2007 Sep; 14(3):633-43. PubMed ID: 17914094
[TBL] [Abstract][Full Text] [Related]
2. MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer.
Tovar C; Higgins B; Kolinsky K; Xia M; Packman K; Heimbrook DC; Vassilev LT
Mol Cancer; 2011 May; 10():49. PubMed ID: 21539745
[TBL] [Abstract][Full Text] [Related]
3. Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance.
Inder S; Bates M; Ni Labhrai N; McDermott N; Schneider J; Erdmann G; Jamerson T; Belle VA; Prina-Mello A; Thirion P; Manecksha PR; Cormican D; Finn S; Lynch T; Marignol L
Sci Rep; 2019 Nov; 9(1):17325. PubMed ID: 31758038
[TBL] [Abstract][Full Text] [Related]
4. Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.
Eke I; Makinde AY; Aryankalayil MJ; Reedy JL; Citrin DE; Chopra S; Ahmed MM; Coleman CN
Mol Cancer Res; 2018 Dec; 16(12):1855-1864. PubMed ID: 30042176
[TBL] [Abstract][Full Text] [Related]
5. A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.
Maximov PY; Abderrahman B; Curpan RF; Hawsawi YM; Fan P; Jordan VC
Endocr Relat Cancer; 2018 Feb; 25(2):R83-R113. PubMed ID: 29162647
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer.
Paczkowski M; Kretzschmar WW; Markelc B; Liu SK; Kunz-Schughart LA; Harris AL; Partridge M; Byrne HM; Kannan P
Commun Biol; 2021 Jan; 4(1):6. PubMed ID: 33398023
[TBL] [Abstract][Full Text] [Related]
7. Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells.
Iwanaga M; Kawamura H; Kubo N; Mizukami T; Oike T; Sato H; Miyazawa Y; Sekine Y; Kawabata-Iwakawa R; Nishiyama M; Ohno T; Nakano T
J Radiat Res; 2022 Jul; 63(4):585-590. PubMed ID: 35589101
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling.
Wu CT; Huang YC; Chen WC; Chen MF
Front Oncol; 2021; 11():619365. PubMed ID: 34109109
[TBL] [Abstract][Full Text] [Related]
9. The Response of Prostate Cancer to Androgen Deprivation and Irradiation Due to Immune Modulation.
Wu CT; Chen WC; Chen MF
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30587810
[TBL] [Abstract][Full Text] [Related]
10. The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.
Redfern AD; Spalding LJ; Thompson EW
Clin Exp Metastasis; 2018 Apr; 35(4):285-308. PubMed ID: 29948647
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1 mediates the radiation response of prostate cancer.
Wu CT; Hsieh CC; Yen TC; Chen WC; Chen MF
J Mol Med (Berl); 2015 Jan; 93(1):73-82. PubMed ID: 25228112
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-6 in the radiation response of prostate cancer.
Wu CT; Chen MF; Chen WC; Hsieh CC
Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095
[TBL] [Abstract][Full Text] [Related]
14. Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy.
Chiu HW; Fang WH; Chen YL; Wu MD; Yuan GF; Ho SY; Wang YJ
PLoS One; 2012; 7(7):e40462. PubMed ID: 22802963
[TBL] [Abstract][Full Text] [Related]
15. Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.
Wu CT; Hsieh CC; Lin CC; Chen WC; Hong JH; Chen MF
J Mol Med (Berl); 2012 Nov; 90(11):1343-55. PubMed ID: 22660275
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets for radiation oncology in prostate cancer.
Wang T; Languino LR; Lian J; Stein G; Blute M; Fitzgerald TJ
Front Oncol; 2011; 1():17. PubMed ID: 22645712
[TBL] [Abstract][Full Text] [Related]
17. Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.
Dai Y; Desano J; Qu Y; Tang W; Meng Y; Lawrence TS; Xu L
Am J Cancer Res; 2011; 1(2):128-43. PubMed ID: 21804946
[TBL] [Abstract][Full Text] [Related]
18. Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.
Ross AE; Emadi A; Marchionni L; Hurley PJ; Simons BW; Schaeffer EM; Vuica-Ross M
BJU Int; 2011 Aug; 108(3):447-54. PubMed ID: 21176082
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA methyltransferase 1 in hormone-resistant prostate cancer.
Chen MF; Chen WC; Chang YJ; Wu CF; Wu CT
J Mol Med (Berl); 2010 Sep; 88(9):953-62. PubMed ID: 20544341
[TBL] [Abstract][Full Text] [Related]
20. The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
Xie BX; Zhang H; Yu L; Wang J; Pang B; Wu RQ; Qian XL; Li SH; Shi QG; Wang LL; Zhou JG
Asian J Androl; 2010 May; 12(3):405-14. PubMed ID: 20118949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
